Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease

NCT00426153 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00426153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00426153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease
Lead sponsor
Mayo Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2008
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, hepatomegaly, kidney, polycystic, liver diseases, polycystic kidney, autosomal dominant, polycystic liver disease